Drug Target Review

NOVEMBER 20, 2023

Distinguishing tumours Dr Anand Kumar of the Athinoula A Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) said: “Our lab has been studying fluorescence lifetime imaging since 2002, but this is the first time that anyone has combined it with tumour imaging and injectable dyes in humans.

FDA Approval 105

FDA Approval Clinical Trials FDA Treatment 105

Eye on FDA

AUGUST 2, 2022

By 2002, the number had dropped to 28, reviving somewhat by the end of that decade when it reached 52 in 2010. But when it comes to enforcement things have changed greatly over the years. In 1998, there were 156 letters issued in a single year.

Pharmaceutical Companies 88

Pharmaceutical Companies FDA Pharmaceuticals Drugs 88

Common Sense for Drug Policy Blog

OCTOBER 4, 2024

Changes in Criteria for Identifying Cannabis Dependence: From DSM-IV to DSM-V "Based on NSDUH estimates, rates of cannabis abuse and dependence remained relatively stable from 2002 to 2019, with the highest rates of abuse and dependence among young adults (aged 18–25) (Figure 3-27).

Engineering 52

Engineering Science 52

National Institute on Drug Abuse: Nora's Blog

FEBRUARY 1, 2024

The Drug Abuse Treatment Act of 2002, for instance, enabled the newly approved medication buprenorphine, developed through NIDA research, to be prescribed by regular physicians if they obtained a waiver.

Science 122

Science FDA Approval Treatment Research 122

Common Sense for Drug Policy Blog

DECEMBER 28, 2023

The former NHSDA was redesigned in 1999, and other changes were made to the survey in 2002, which may have increased the sensitivity of the NSDUH for identifying people who are binge drinking and alcohol dependent. Differences in the prevalence of alcohol dependence between the current study and the 2002 study in New Mexico (10.7%

Production 52

Production Treatment Drugs 52

The Pharma Data

JANUARY 4, 2021

from Taipei City Hospital in Taiwan, and colleagues used linked data from the Taiwan National Health Insurance data set and the Taiwan Death Registry (2002 through 2016) to compare the risk for suicide in 35,891 patients with PD versus 143,557 matched control participants. MONDAY, Jan. 16 in JAMA Psychiatry. Ying-Yeh Chen, M.D.,

Disease 52

Disease Hospitals Research 52

The Pharma Data

OCTOBER 16, 2020

from Kosin University Gospel Hospital in South Korea, and colleagues used data from 732,199 individuals who had undergone a national health check-up in 2002 to 2003. FRIDAY, Oct. 16, 2020 — Use of aspirin , metformin , and statins is associated with a lower risk for lung cancer mortality, according to a study published online Sept.

Hospitals 52

Hospitals Research Drugs 52

The Pharma Data

MARCH 23, 2021

In the interview, Mr. Reinhardt was asked about the company’s $678 million settlement last year with the United States Government, which resolved claims that during the time period from 2002 to 2011, Novartis used certain promotional programs as a way improperly to induce doctors to prescribe Novartis products, in violation of US anti-kickback law.

Doctors 52

Doctors Government Production 52

Broad Institute

OCTOBER 17, 2023

She’d always had an interest in genetics research and moved to Boston in 2002 to work for a genetics-focused startup. Deik received her bachelor's degree in botany from Connecticut College and immediately went to work at International Paper, a paper manufacturing company, where she engineered trees to grow faster.

Research 98

Research Small Molecule Science Disease 98

Common Sense for Drug Policy Blog

DECEMBER 15, 2023

It showed little change in its usage levels through 2002. Ketamine Use by Students in the US "Prevalence of past-12 month use of ketamine (another “club drug”) among 12th grade students has been below 2% for the past decade and in 2022 stood at 1.2%. This “club drug” was added to the survey in 2000. Since then use has declined in all grades.

Drugs 40

Drugs Research 40

Common Sense for Drug Policy Blog

JUNE 4, 2023

One study demonstrated that the homeless use SCRA to escape from the realities of the streets and provide relief from physical and mental health conditions, similar to the motivations for using cannabis, heroin and crack cocaine within the population (Fountain and Howes 2002 ; Link, 2014 ; Peacock et al., Van Calster, P.

40

40

Common Sense for Drug Policy Blog

AUGUST 22, 2023

The risk environments framework provides a theoretical foundation for doing so ( Rhodes, 2002 ), emphasising the importance of enabling contexts and resources in advancing harm reduction ( Duff, 2009 , 2011 ). 2023 ; Piatkowski et al., 2022 , 2023 a).

Drugs 52

Drugs 52

NIH Director's Blog: Drug Development

OCTOBER 11, 2022

2002, 41 (14), 2596–2599. [3] 2002, 67 (9), 3057–3064. [4] Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. 3] Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. Tornøe CW, Sengeløv H, Meldal M.

Research 52

Research Small Molecule Science Clinical Research 52

The Pharma Data

JANUARY 21, 2021

In this study, researchers analyzed records for 5,417 adults and children diagnosed with lupus since 2002 at all U.S. The condition can be fatal, and often causes debilitating bouts of fatigue and pain that prevent nearly half of adult patients from working. Previous estimates of lupus were larger but unverified.

Clinical Trials 52

Clinical Trials Disease Treatment Trials 52

The Pharma Data

NOVEMBER 10, 2020

The new study included thousands of British children born between 2000 and 2002. They were assessed at ages 3, 5, 7, 11 and 14 using questionnaires about their strengths and difficulties, which had been completed by parents and teachers.

Hospitals 52

Hospitals Science Research Disease 52

FDA Law Blog: Drug Discovery

JUNE 11, 2023

Between 2002 and 2019, there were 768 products with pediatric labeling changes under BPCA and/or PREA. However, given FDA’s prior announced policy, it is somewhat surprising that only 16% of pediatric labeling changes pursuant to BPCA and/or PREA between 2002 and 2019 were conducted under both the BPCA and PREA.

FDA 40

FDA Drug Development Production Drugs 40

The Pharma Data

NOVEMBER 23, 2020

In addition to his roles at Legend, Zhang has also been the chairman, an executive director and CEO of GenScript, which he cofounded in 2002. Legend said it did not anticipate any charges being brought against the company in relation to the arrest. Zhang had served as the chairman of board of directors of Legend Biotech since 2015.

Government 52

Government Molecular Biology Regulations Laboratories 52

Drug Target Review

FEBRUARY 29, 2024

Dr Van Laar has been researching neuroprotective approaches for Parkinson’s disease since 2002, with her research efforts focused on mechanisms of neurodegenerative diseases and the therapeutic potential of gene therapy.

Therapies 111

Therapies Disease Clinical Trials Science 111

Common Sense for Drug Policy Blog

JUNE 4, 2023

Although this bill in 2002 was never passed, it was reintroduced in US Congress the following year as the Illicit Drug Anti-Proliferation Act which made it illegal to knowingly lease, rent, or use a space for the purpose of distributing or using controlled substances.

Drugs 40

Drugs International 40

FDA Law Blog: Biosimilars

NOVEMBER 9, 2023

The requirement for prior notice originates in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act). “Prior notice” informs FDA about the products it can expect to be offered for import into the country. food supply and other food-related emergencies.

Regulations 52

Regulations FDA Compliance International 52

The Pharma Data

FEBRUARY 22, 2022

After ten years at Sony France as Chief Financial Officer (2000-2002), and then General Secretary, she was appointed Chief Financial Officer of Europacorp Group in 2011. She began her career in 1992 at PricewaterhouseCoopers where she worked as an auditor and then a financial advisor.

Clinical Trials 52

Clinical Trials DNA Science Clinical Development 52

The Pharma Data

FEBRUARY 12, 2022

These coronaviruses include SARS-CoV-1, which killed about 800 people, mostly in Asia, in a series of outbreaks in 2002-04; MERS-CoV, which has killed about 900 people, mostly in the Middle East, since 2012; and, of course, SARS-CoV-2, which by now has killed over 5 million people worldwide in the COVID-19 pandemic.

Virus 52

Virus Vaccine Therapies Research 52

The Pharma Data

NOVEMBER 18, 2020

is a Taiwan biopharmaceutical company that was established in 2002. The above poster presentations will be available online at www.obipharma.com on November 23, 2020. About OBI Pharma. OBI Pharma, Inc.,

Vaccine 52

Vaccine Small Molecule Immune Response Hospitals 52

Drug Target Review

JUNE 29, 2023

Regarding the NY-ESO programme that we worked on, I started work on that in 2002 before we even knew that we were going to do cell therapy. I think the cell-therapy field has evolved a lot – and is continuing to do so – in the time I’ve been working with this.

Therapies 115

Therapies Science Cell Biology Production 115

Drug Target Review

MAY 11, 2023

Elsevier Current Trends; 2002 [cited 2023Apr25]. References: David Bertwistle, Abstract Mutations in the BRCA1 and BRCA2 genes confer a high risk of breast cancer development [Internet]. Current Opinion in Genetics & Development. Available from: [link] RAD51 gene family structure and function – annual reviews [Internet].

DNA 52

DNA Treatment Research International 52

The Pharma Data

JANUARY 14, 2021

” For the study, the researchers collected data on more than 3,100 heart attack patients who had angioplasties between 2002 and 2011. . “This is especially important in the COVID-era given patients having greater reticence to come to hospitals, leading to larger heart attacks and higher rates of mortality and heart failure.”

Hospitals 52

Hospitals Treatment Doctors Research 52

Common Sense for Drug Policy Blog

DECEMBER 20, 2023

By giving people who use drugs the opportunity to consume in a calm, hygienic and supervised environment DCRs also aim to reduce harms resulting from the broader ‘risk environment’ that socially marginalised or excluded groups may be exposed to as a consequence of multiple interacting physical, social, economic and policy factors (Rhodes, 2002). "In

Drugs 40

Drugs Disease Marketing 40

Drug Target Review

JUNE 19, 2024

From 2002 until 2004, Mr Culley was Director of Business Development and Marketing for Immusol, Inc. Mr Culley served from 2007 to 2010 as Mast’s Chief Business Officer and Senior Vice President, from 2006 to 2007 as Mast’s Senior Vice President, Business Development, and from 2004 to 2006 as Mast’s Vice President, Business Development.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

The Pharma Data

MAY 14, 2021

Complete Confidence – I was professionally trained at the London College of Clinical Hypnosis 2002-2003. Affordable – My Gastric Band Hypnotherapy Pack is about ten times less expensive than visiting a private hypnotherapist. I’ve treated thousands of clients both offline and online over nearly two decades.

Production 52

Production Vaccine 52

Drug Target Review

DECEMBER 13, 2024

Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022. Zhou W, Xu Z, Liu S, Lou X, Liu P, Xie H, et al. BMC Cancer. 2024;24(1):898. Wiedemeyer WR, Gavrilyuk J, Schammel A, Zhao X, Sarvaiya H, Pysz M, et al.

Therapies 98

Therapies Treatment Clinical Trials Drugs 98

PLOS: DNA Science

JUNE 1, 2023

DEB has been a candidate for a gene therapy since 2002. RDEB is inherited from two carrier parents. A dominant form – DDEB – is less severe, blistering the hands, feet, knees, and elbows. This DNA Science post from 2018 traces the history of the efforts.

FDA Approval 52

FDA Approval Therapies FDA Disease 52

Agency IQ

JUNE 9, 2023

Context on the new guidance In 2002, FDA issued a guidance document on the conduct of IND-enabling nonclinical immunotoxicology studies. Overall, the concepts laid out in the S8 Guideline were well-aligned with FDA’s 2002 guidance. As a result, parts of the original guidance were widely considered to be outdated or unnecessary.

FDA 40

FDA Small Molecule Science Immune Response 40

Common Sense for Drug Policy Blog

JUNE 4, 2023

Ecstasy, in particular, has a long history of adulteration ( Hayner, 2002 ; Morelato et al., History of Drug Checking "The adulteration of illicit drugs is not a new phenomenon, with evidence of it occurring as early as the 1930s ( Morgan, 1982 ).

Drugs 40

Drugs International Marketing 40

NIH Director's Blog: Drug Development

MARCH 18, 2021

He and others had been working on closely related coronaviruses for years, inspired by earlier outbreaks, including SARS in 2002 and Middle East respiratory syndrome (MERS) in 2012 (although MERS apparently came from camels). But Veesler doesn’t consider himself a visionary by expanding his research to bats.

Virus 52

Virus Immune Response Clinical Trials Treatment 52

The Pharma Data

MARCH 16, 2022

The former Chairman of the Supervisory Board, who died in 2002, promoted intensive contact with academia and supported the university education of up-and-coming scientists. The award was established in 2000 by Professor Kurt Hansen, former Chairman of the Board of Management and Supervisory Board at Bayer AG.

Cell Biology 52

Cell Biology Molecular Biology Science Research 52

Common Sense for Drug Policy Blog

SEPTEMBER 12, 2020

In April 2002, Kevin debated DEA Administrator Asa Hutchinson at a conference hosted by Rice University's James Baker Institute. He spoke at nationally recognized legal seminars and testified before Congress on drug related issues. 2005 interview with Kevin on the syndicated radio program Cultural Baggage is available.

Doctors 40

Doctors Government Drugs International 40

NIH Director's Blog: Drug Development

MAY 15, 2018

2002 Oct 3;419(6906):498-511. [3] 3] Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Zhang M, Wang C, Otto TD, Oberstaller J, Liao X, Adapa SR, Udenze K, Bronner IF, Casandra D, Mayho M, Brown J, Li S, Swanson J, Rayner JC, Jiang RHY, Adams JH.

Drug Development 52

Drug Development Drugs Disease Treatment 52